Why Oyster Point Pharma Stock Is Sinking Today

·2-min read
Why Oyster Point Pharma Stock Is Sinking Today

The FDA approval of nasal spray Tirvaya didn't include data needed for the company to receive the second tranche in its credit facility.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting